| Term 
 
        | 2 parts to Innate immunity |  | Definition 
 
        | Bloodborn and physical barriers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Innate immunity (physical barriers) Inflammatory response (protect from further injury, prevent infection, promote healing/repair)
 Adaptive immunity (target invaders, memory)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | present at birth prevents damage from environ (ROS)
 Prevent infection by invaders
 |  | 
        |  | 
        
        | Term 
 
        | 4 sites of infection prevention |  | Definition 
 
        | normal flora (skin and gut) skin
 mucous membranes
 stomach acid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tightly associated cells of the skin, and linings of GI, GU, and respiratory tracts |  | 
        |  | 
        
        | Term 
 
        | ___ is associated with psoriasis, influenza, inflammatory bowel disease and human immunodeficiency virus(HIV) |  | Definition 
 
        | Dysregulated barrier function |  | 
        |  | 
        
        | Term 
 
        | Protective Function of Epithelial Cells |  | Definition 
 
        | Secrete biochemical substances that protect against infection Create acidic environment
 Mucus
 Earwax
 Perspiration
 Saliva
 Tears
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonpathogenic microorganisms that reside on the body’s surface
 
 Bacteria and fungi specific to that location
 |  | 
        |  | 
        
        | Term 
 
        | 3 Functions of normal flora |  | Definition 
 
        | GI tract: digest fatty acids, large polysaccharides, produce biotin, Vitamin K, aid in absorption of various ions (Ca, Fe, Mg) Block attachment to the epithelium; inhibit colonization
 Long term antibiotic use alters normal flora
 |  | 
        |  | 
        
        | Term 
 
        | 2 important opportunistic pathogens |  | Definition 
 
        | Candida albicans (yeast infec; thrush in mouth, skinfolds) Clostridium difficile colitis (assoc. w/antibiotic use)
 |  | 
        |  | 
        
        | Term 
 
        | Inflammatory Response (itis) is the ___ line of defense |  | Definition 
 
        | 2nd line of defense; physical barrier has been breached Interaction between humoral & cellular events
 |  | 
        |  | 
        
        | Term 
 
        | 4 Characteristics of inflammatory response |  | Definition 
 
        | Occurs in tissue with blood supply Activated within seconds after injury
 Involves cellular & chemical components
 General; non-specific
 |  | 
        |  | 
        
        | Term 
 
        | Inflammatory process 3 phases |  | Definition 
 
        | Vascular permeability Recruitment and emigration of leukocytes
 Phagocytosis of antigens and debris
 |  | 
        |  | 
        
        | Term 
 
        | Inflammatory process detailed |  | Definition 
 
        | Injury -->adhesion and attraction-->vasodilation-->neutrophils and macrophages-->phagocytosis |  | 
        |  | 
        
        | Term 
 
        | Increased Vascular Permeability |  | Definition 
 
        | Brief  vasoconstriction following injury → Release of histamine, prostaglandins, leukotrienes →  Endothelial cells contract & round up →
 Increase capillary permeability (vasodilation) →
 Increase hydrostatic pressure →
 Fluid is pushed out into the tissue →
 Swelling
 |  | 
        |  | 
        
        | Term 
 
        | Cardinal signs of inflammation |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mast cell degranulation releases: Histamine
 Leukotrienes
 Prostaglandins
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Early mediator Released by mast cells, basophils
 Potent vasodilator; ↑ capillary permeability
 Reduces BP if release is excessive
 Causes bronchial constriction and mucus production
 Present in allergic reactions, hay fever, skin reactions
 treated w/histamine receptor antagonist (blocker)
 2 types, H1 and H2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Phospholipids formed from arachidonic acid (AA metabolization); cyclooxgenase pathway -Vasodilation; ↑ capillary permeability
 -Pain (direct effect on nerves)
 -Arise from the cyclooxgenase (COX) pathway
 -Found in various tissue
 -ASA inhibits COX pathway
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Phospholipids formed from arachidonic acid (AA); lipooxygenase pathway -5 subtypes
 -Chemotactic, smooth muscle contraction,
 bronchospasm, ↑ capillary permeability
 -Leukotriene receptor blockers (asthma)
 |  | 
        |  | 
        
        | Term 
 
        | Other chemical mediators of inflammation |  | Definition 
 
        | -cytokines (IL interleukin): peptides produced by macrophages, monocytes, neutrophils, B & T lymphs, fibroblasts, & ECs that communicate between immunity and inflammatory responses; pro and anti-inflammatory -interferons (cytokine): prevent invasion of viruses, parasites
 -chemokines (cytokine): chemotactic; WBCs; adhesion molecules
 |  | 
        |  | 
        
        | Term 
 
        | Recruitment & emigration of leukocytes
 |  | Definition 
 
        | bring in the white blood cells |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Neutrophils normally rolls along the wall of the endothelium (pavementing ) -Injured EC  become sticky (selectins) and adhere to the wall
 -Move through the vessel wall (integrins)
 -Migrate to tissue
 -Chemotaxis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Neutrophils and monocytes enter tissue and produce enzymes that can digest protein tissue -Large number of neutrophils  → acute
 -Large number of monocytes & macrophages → chronic inflammation
 -Inhibited by alpha1-antiproteases
 -Granuloma (localized mass of inflamed tissue that could not be phagocytized)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Localized symptoms -Systemic symptoms
 --Macrophage-derived cytokines responsible for effects (IL-6, IL-10, TNF-α) interleukin, tumor necrosis factor
 --Fever, lethargy, neutrophilia, muscle catabolism
 --Induction of acute phase proteins from liver
 --Biomarker are non-specific: SED rate, CRP or hs-CRP
 |  | 
        |  | 
        
        | Term 
 
        | Disorders Associated with Inflammation |  | Definition 
 
        | Arthritis Hypertension (HTN)
 Atherosclerosis
 Inflammatory bowel disease (IBD)
 Acne
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Regeneration of tissue Exudates transport leukocytes & Ab, dilute toxins, transport nutrients for repair
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Serous Serosanguinous
 Fibrous
 Purulent
 hemorrhagic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sed rate or ESR (erythrocyte sedimentation rate) CRP C-reactive protein
 CBC complete blood count
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Hypersensitivity Reactions |  | Definition 
 
        | Type I- allergic reaction; anaphylaxis Type II- autoimmune; loss of self
 Type III-antigen-antibody complex precipitates out in blood and deposits in tissue
 Type IV- cytotoxic cell-mediated reactions
 |  | 
        |  | 
        
        | Term 
 
        | Type I: Allergic Reaction |  | Definition 
 
        | most common 
 -Mediated by IgE antibody
 -Allergen (antigen) is recognized by B cell
 -B cells make IgE antibodies against the allergen
 -IgE binds the antigen, basophil, mast cell
 -Degranulation
 *Release of histamine, cytokines, chemokines, leukotrienes
 -Immediate
 4 cardinal signs of inflammation
 
 specific to the area
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Medical emergency -Rapid IgE response after exposure to an antigen
 -Massive histamine-induced dilation
 -Circulatory and airway collapse
 -Itching, abdominal cramping, flushing of the skin, GI upset, breathing difficulties
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -IgG or IgM antibodies attack tissue antigens
 -Loss of recognition of self
 
 
 
 Transfusion reaction
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antigen-antibody complex is deposited in tissue Activate complement and mast cell degranuation
 
 Glomerular nephritis
 Systemic lupus erythematosus (SLE)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Mediated by T cells -Delayed taking 24-72 hours
 -helper T cells are activated by an antigen
 -Proinflammatory cytokines
 
 
 can be considered a Delayed allergic reactions
 Poison ivy is an example of type IV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-inflammatory Properties (NSAIDS) -ASA
 -Ibuprofen (Advil, Motrin)
 -Naproxen (Aleve)
 -Celecoxib (Celebrex)
 Lacking anti-inflammatory properties
 -Acetominophen (Tylenol)
 *MOA: inhibit cyclooxygenase (COX) the enzyme that converts AA into prostanoids (PGs etc)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX 1 Stomach
 Platelets
 Kidney
 
 
 COX 2
 Blood vessels
 Kidney
 Injured tissue
 Brain
 Colon
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: cannot inhibit PG synthesis outside the CNS No anti-inflammatory effects
 Does not supress platelts aggregation, gastric ulceration, decrease renal bloodflow
 Overdose-severe liver injury
 |  | 
        |  | 
        
        | Term 
 
        | Acetaminophen (and aspirin) overdose reversal agent |  | Definition 
 
        | Acetylcysteine-restores glutathione to help the liver metabolize again |  | 
        |  | 
        
        | Term 
 
        | Systemic Steroids for Anti-Inflammatory |  | Definition 
 
        | Focus on glucocorticoids hydrocortisone
 cortisone
 prednisone
 methylprednoisine
 dexamethasone
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Regulates metabolism Regulates stress response
 Immunoresponse
 Effects on CNS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA (same if endogenous or synthetic) 
 Mediated by a specific intracellular receptor (GR);natural and synthetic steroids enter cells rapidly and interact with these intracellular receptors; resulting complexes modulate the transcription rate of specific genes and lead to an ↑↓ in the levels of specific proteins
 |  | 
        |  | 
        
        | Term 
 
        | Glucocorticoids (GCS) 3 Anti inflammatory and anti-immunity effects |  | Definition 
 
        | Influence leukocyte migration, antigen processing, eosinophils and lymphatic tissues Inhibit mediators (cytokines, prostaglandins) & phagocytosis
 Inhibit accumulation of neutrophils, monocytes at the site of inflammation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Relief of inflammatory symptoms Treatment of allergies
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid soluble; protein bound but not albumin Metabolized by liver (CYP 450)
 Excreted by kidney
 Substantial lag time to
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | pharmalogic dose is greater than the physiologic dose PO, IV, topical
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenal insufficiency *Osteoporosis and resultant fractures
 *Infection
 *Glucose intolerance
 *Myopathy
 Fluid and electrolyte disturbances
 Growth retardation
 *Psychologic disturbances
 Cataracts and glaucoma
 Peptic ulcer disease
 Iatrogenic Cushing’s syndrome
 Use in pregnancy and lactation
 |  | 
        |  | 
        
        | Term 
 
        | GCS and Adrenal suppression: Why can it develop? |  | Definition 
 
        | Adrenal suppression and physiologic stress Glucocorticoid withdrawal
 Taper the dosage over 7 days
 Switch from multiple doses to single doses
 Taper the dosage to 50% of physiologic values
 Monitor for signs of insufficiency
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Highly individualized Determined empirically (trial and error)
 No immediate threat – start low and slow
 Immediate threat – start high; decrease as possible
 Long-time use – smallest effective amount
 Prolonged treatment with high doses only if disorder is life-threatening or has potential to cause permanent disability
 Increase in times of stress
 Wean gradually
 Alternate-day therapy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Side effect is not a drug allergy 
 Hypotension, fatigue is not a true drug allergy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hypersensitivity reaction is a drug allergy Hives, wheezing, angioedema (true drug allergy)
 
 Treated with anti-histamine
 |  | 
        |  | 
        
        | Term 
 
        | Steven Johnson’s Syndrome |  | Definition 
 
        | Rare 1- 14 days after drug has been started
 Skin starts sloughing off, linings of mucus membranes also
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Swelling of the lips and tongue Airway can close
 Life-threatening
 Call 911
 STOP THE DRUG
 |  | 
        |  | 
        
        | Term 
 
        | Common allergy-causing drugs |  | Definition 
 
        | -Sulfa drugs -Anticonvulsants
 -Insulin preparations (particularly animal sources of insulin)
 -Iodinated (containing iodine) x-ray contrast dyes (these can cause allergy-like anaphylactoid reactions)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | “An unpleasant sensory and emotional experience associated with actual or potential tissue damage” –IASP 
 “Whatever the experiencing person says it is, existing whenever the experiencing person says it does” –McCaffery
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cognitive emotional
 motivational
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 7 rights: American Pain Foundation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ronald Melzack & Patrick Wall Small nerve fibers: pain receptors
 Large nerve fibers: “normal“ nerve fibers (touch, pressure, vibration)
 So, the more large fiber activity relative to thin fiber activity at the inhibitory cell, the less pain is felt.
 This explains why we rub a smack.
 |  | 
        |  | 
        
        | Term 
 
        | Nociception: The Pain Process |  | Definition 
 
        | Transduction Transmission
 Perception
 Modulation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Process of converting noxious stimuli to an action potential or nociceptive impulse, activating nociceptors. Nociceptors are stimulated
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct damage to the nerve endings Chemicals released at the site of tissue injury (serotonin, bradykinin, histamine, prostaglandins) stimulate a primary afferent nociceptor (PAN) to initiate an action potential
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Activated nerve fibers transmit the nociceptive impulse from the PNS to the CNS. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Larger, thinly myelinated Skin
 Thermal, mechanical stimuli
 Fast traveling, "first pain"
 HIghly localized 'sharp, stinging, cutting'
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Smaller, unmyelinated Muscle, connective tissue, viscera
 Thermal, mechanical, chemical
 Slower traveling 'second pain'
 Poorly localized, more diffuse "dull, burning, achy"
 |  | 
        |  | 
        
        | Term 
 
        | Ascending Spinal Pathways |  | Definition 
 
        | Neospinothalamic Tract Paleospinothalamic Tract
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A delta fibers transmit impulses Transmit painful stimuli quickly and directly to thalamus and cortex
 Thalamus interprets info about the nature & location of the stimuli more quickly
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | C fibers transmit impulses Pain impulses to medulla, midbrain, part of thalalmus
 Activate limbic system (emotional center ) and reticular formation (sleep-wake cycle)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Awareness & interpretation of pain from the results of neural processing of the painful stimulus Involves several brain structures
 Great variability in pain experiences
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pain Threshold: lowest intensity of a painful stimulus that is perceived. Varies on physiological factors. Pain Expression: An individual’s response to pain, highly variable.
 Pain Tolerance: Maximum degree of pain intensity a person is willing to tolerate before seeking relief.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alcohol drugs
 hypnosis
 warmth
 distraction
 rubbing
 faith, strong beliefs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | fatigue anger
 boredom
 anxiety
 persistent pain
 stress
 depression
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Modulation occurs via descending pathways. Neuromodulators: endogenous opioids
 |  | 
        |  | 
        
        | Term 
 
        | 4 Neuromodulators: endogenous opioids |  | Definition 
 
        | Protein hormones in the brain Modulate nociceptor impulse inhibition
 Endorphins: both endogenous & morphine
 PAG area releases endorphins producing analgesic effects, blocking pain in the brain.
 Enkaphalins: found in the thalamus
 Inhibit substance P release in the pathway, decreasing pain signal transmission in the spinal cord
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mu, Kappa, sigma, delta receptors Mu & Kappa: analgesic effects
 Mu receptors: brainstem, limbic system, dorsal horn
 Kappa receptors: spinal cord – modulate pain via descending pathways.
 |  | 
        |  | 
        
        | Term 
 
        | Morphine predominantly work on . . . |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nociceptive Pain Characteristics |  | Definition 
 
        | Caused by tissue damage Stimulated by healthy, intact nociceptive afferent nerve fibers
 Somatic & Visceral pain
 Sharp, dull, aching sensations
 |  | 
        |  | 
        
        | Term 
 
        | Neuropathic Pain Characteristics |  | Definition 
 
        | Caused by damage to nerve tissue Characterized as unrelieved & persistent
 Acute pain without sufficient relief may become neuropathic
 Cramping, shooting, stabbing, burning sensations
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Onset: Time of occurrence Duration: Acute vs chronic
 Severity/Intensity: 0 - 10
 Mode of Transmission: Pain pathways vs referred pain
 Location/Source: Superficial, deep, central
 Causation: Nociceptive, neuropathic, psychophysiologic
 Causative force/agent: spontaneous, self-inflected, etc.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cutaneous/Superficial Pain |  | Definition 
 
        | Caused by injury to the skin / superficial tissues Well-defined, localized pain for short duration
 Relatively uncomplicated
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Originates from ligaments, tendons, bones Activated nociceptors on the body surface or musculoskeletal tissues (musculoskeletal pain)
 Generally diffuse, sharp, dull, aching
 Longer duration, less localized
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Originates from viscera / internal organs Caused by compression or injury in and around organs
 Longer duration than somatic pain
 Diffuse, poorly localized, vague, dull, generalized aching, squeezing pain
 May radiate in other areas in the body: referred visceral pain (even harder to pinpoint location)
 Nerve fibers innervating body organs for the SNS to the spinal cord, so may have SNS s/s.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pain in an area distant from the site of painful stimuli Occurs most often with damage or injury to visceral organs
 Associated with interneurons or segments in the dorsal horn
 Can be intense with little or no pain at the site of noxious stimuli
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sudden or profound loss of blood flow to the tissue causing hypoxia & injury, releasing inflammatory & pain-producing chemicals Aching, burning, pricking pain
 
 Example: cardiac tissue ischemia causes visceral pain radiating to the arm or jaw
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | thrombus or embolus formation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | pain may develop gradually; cramping |  | 
        |  | 
        
        | Term 
 
        | Cancer-Related / Malignant Pain |  | Definition 
 
        | Have qualities of both acute and chronic pain Have an identifiable cause
 Results from infiltration/compression of organs by and expanding tumor size or from cancer treatments
 Bone metastasis cause most extreme pain
 |  | 
        |  | 
        
        | Term 
 
        | Neurologic Pain: Radiculopathy |  | Definition 
 
        | pain, numbness, tingling, weakness along the nerve Caused by mechanical compression or irritation of the spinal nerve
 Most common areas: lumbar & cervical spine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Area of skin innervated by a single nerve root Pain follows in a dermatome
 Blueprint for a location of source of neurologic pain
 |  | 
        |  | 
        
        | Term 
 
        | Physiological Responses to Pain |  | Definition 
 
        | Physiological: Sympathetic Eyes: Dilated pupils
 Mouth: Inhibited flow of saliva
 Heart: Increased HR, BP, Resp
 Lungs: Dilates bronchioles to increase oxygenation
 Gut: Peristalsis & secretion inhibited  n&v
 Liver: Conversion of glycogen to glucose
 Adrenals: Secretion of adreneline
 Bladder: Urinary retention
 |  | 
        |  | 
        
        | Term 
 
        | Psychological Responses to Pain |  | Definition 
 
        | Fear Anxiety
 Helplessness
 Depression
 Suffering
 Hopelessness
 Distress
 Decreased will to live
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pain from stimuli which are not normally painful.  The pain may occur other than in the area stimulated.  Allodynia means “other pain.” |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A burning pain and sensitivity to vibration or touch, usually in the hand or foot, at a site removed from an injury of a peripheral nerve that has healed |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An unpleasant abnormal sensation, which may be spontaneous or evoked, experienced by patients with neuropathic pain; distinct from pain in the classical sense |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A type of neuropathic pain that manifests as an episodic shooting, stabbing, or knifelike pain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | An abnormal sensation (like“pins & needles”) which may be spontaneous or evoked, often in patients with neuropathic pain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A disease or degenerative state in which motor, sensory, vasomotor nerve fibers may be affected.  May manifest as muscle weakness and atrophy, pain, or numbness |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Character & quality -Pattern
 -Intensity
 -P – what provokes the pain (aggravating factors) & palliative measures (alleviating factors)
 -Q – quality of pain
 -R – region & radiation of pain
 -S – severity (quantity) & setting
 -T – timing
 -Aggravating/Alleviating Factors
 -Personal meaning: how pain affects life
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | American Pain Society 12 Principles of Pain Management |  | 
        |  | 
        
        | Term 
 
        | World Health Org (WHO) Pain Control Ladder |  | Definition 
 
        | Step 1: Mild Pain (0-3), start with a nonopioid Step 2: Mild pain that persists or increases & Moderate Pain (4-6), use a weak opioid or opioid-nonopioid combo
 Step 3: Moderate pain that persist or increases & Severe pain (7-10), use a strong opioid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dose of one analgesic that is equivalent in pain-relieving effects to another analgesic Allows substitution of analgesics
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Opioid analgesics: act on the CNS to alter the perception of pain Non-opioid analgesics: block impulses in the periphery  and decrease prostaglandin synthesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | enhance pain relief when used in conjunction with analgesics |  | 
        |  | 
        
        | Term 
 
        | 4 Pharmacotherapy Guidelines |  | Definition 
 
        | 1. Aim for monotherapy 2.  Medication must result in…
 -Improved pain control
 -Tolerable side effects
 3. Both provider and patient must recognize individual variability
 4. Slow titration until…
 -Significant pain relief
 -Intolerable side effects
 |  | 
        |  | 
        
        | Term 
 
        | Non-Opioid Analgesics Examples |  | Definition 
 
        | Acetaminophen Aspirin
 Traditional NSAIDs
 COX-2 Inhibitors
 : Tylenol, Bayer, Advil, Celebrex
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | primary site for opiate effects; produce analgesia, euphoria, sedation, respiratory depression, physical dependence |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | produce analgesia, sedation, and psychotomimetic effects |  | 
        |  | 
        
        | Term 
 
        | Examples of Muscle Relaxants |  | Definition 
 
        | Cyclobenzaprine (Flexeril) Carisoprodol (Soma)
 Methocarbamol (Robaxin)
 Metaxalone (Skelaxin)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | morphine sulfate (eg, Roxanol™, MSIR®) codeine
 hydrocodone (eg, Zydone®, Vicodin®, Lortab®, Vicoprofen®)*
 oxycodone (eg, Roxicodone™, Oxy IR®, Percocet®, Tylox®, Percodan®)*
 hydromorphone (Dilaudid®)
 oxymorphone (Numorphan®)
 fentanyl (Actiq®)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gold standard: Relieves pain without affecting other sensations Most effective for constant, dull pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | methadone sustained-release morphine (eg, MS Contin®, Avinza™; Kadian®, Oramorph®)
 sustained-release oxycodone (Oxycontin®)
 transdermal fentanyl (Duragesic®)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Potent synthetic opioid, 100 times stronger than morphine Rapidly binds to mu receptor
 Used for induction and maintenance of anesthesia during surgery
 Lozenges/lollipops for breakthrough cancer pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Long half-life Cheap!
 Monitor closely for arrhythmias
 
 Should be prescribed by pain or palliative care specialist – unique equianalgesic conversion
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | First synthetic opioid, invented in 1932 as a “safer” alternative to morphine Contraindicated – normeperedine (active metabolite) acts as a CNS stimulant causing seizures & delirium
 |  | 
        |  | 
        
        | Term 
 
        | Patient Controlled Analgesia (PCA) |  | Definition 
 
        | Allows the patient to control the dosage of opioid analgesia received Increased pain relief & patient satisfaction
 Decreased daily dosages & anxiety
 Commonly used for post-op or aggressive new onset pain
 Drugs most frequently used: Morphine, Hydromorphone (Dilaudid)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Less analgesia, decreased respiratory depression , decreased potential for abuse -Codeine: combined with Acetaminophen 300 mg
 T2: 15mg, T3: 30mg, T4: 60mg
 -Oxycodone:
 Combos: +aspirin: Percodan, +acetaminophen: Percocet, +ibuprofen: Combunox
 Controlled release oxycodone: Oxycontin, ATC pain relief given q 12 hours
 -Hydrocodone: most midely prescribed drug in US
 Only available in combination with other drugs
 Combos: +aspirin: Lortab, +acetaminophen: Vicodin, Norco, +ibuprofen: Vicoprofen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Opioid antagonists at both mu & kappa Results in rapid reversal of analgesic effects and side effects of opioids
 1. Naloxone (Narcan) (rapid return of pain, slow injection)
 2. Methylnaltrexone (Relistor) (works on GI tract for const--no return of pain)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Respiratory depression Nausea, vomiting, ileus
 Sedation, mental clouding
 Cough suppression
 Constipation
 Euphoria
 Pruritus
 Urinary retention
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Morphine is the prototype drug Oxycodone has street value
 Hydromorphone has poor oral availability
 Methadone is a great drug, but
 -Negative pre-conceived notions
 -Long half-life that is unpredictable
 Demerol not a good drug for pain as it’s inactive metabolite can cause seizures
 Fentanyl only comes in a patch
 -Great for patients who cannot take PO
 -Hard to titrate
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | over time will need an increase dose to maintain same level of analgesic effect |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | characterized by withdrawal symptoms when drug abruptly stopped |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | demonstrates behaviors of craving and preoccupation with obtaining the drug when pain does not exist & despite physical harm |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | behavior suggestive of addiction caused by undertreatment of pain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Add total of scheduled doses and immediate-release over 24 hour period of all opioids Increase by 50% if initial dose not effective
 Provide breakthrough dosing
 |  | 
        |  | 
        
        | Term 
 
        | Types of Breakthrough Pain |  | Definition 
 
        | -Incident: elicited by specific activities -Spontaneous: occurs unpredictably without warning
 -End of dose failure: pain returns prior to end of interval so increase dose or decrease interval of drug.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analgesia Activities of daily living
 Adverse effects
 Aberrant drug-taking behaviors
 |  | 
        |  | 
        
        | Term 
 
        | Adjuvants - Antidepressants |  | Definition 
 
        | Increases descending pain inhibitory action by preventing reuptake of serotonin & NE Decreases cellular reuptake thus increasing inhibition of nociceptive signal transmission
 Effective for burning type of neuropathic pain
 |  | 
        |  | 
        
        | Term 
 
        | 3 Types of Antidepressants |  | Definition 
 
        | Tricyclics: good for continuous burning, tingling, or allodynia SNRI: good for diabetic neuropathy & polyneuropathy
 SSRI: conflicting data over benefit
 |  | 
        |  | 
        
        | Term 
 
        | Adjuvants - Anticonvulsants |  | Definition 
 
        | Useful for neuropathic pain that is shooting, stabbing, lancinating, burning, tingling Effective for post-herpetic neuralgia, diabetic neuropathy, fibromyalgia
 Gabapentin (Neurontin) works by enhancing the inhibitory NT GABA.
 Carbamazepine (Tegretol) decreases conductance in Na channels
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Steroids - inhibit arachiodonic acid cascade thus inhibiting prostaglandin synth Antihistamines - blocks histamine released by mast cells
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lidocaine - membrane stabilizer, disrupts action potentials in PAN Capsaicin - depletes substance P
 |  | 
        |  | 
        
        | Term 
 
        | Non-pharmacological Methods |  | Definition 
 
        | Distraction Guided imagery
 Hypnosis
 Progressive Relaxation
 Meditation
 Massage
 Transepidural nerve stimulator (TENS)
 Acupuncture
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sensation of tingling, burning, pricking, or numbness of a person's skin with no apparent long-term physical effect |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | term for damage to nerves of the peripheral nervous system,[1] which may be caused either by diseases of or trauma to the nerve or the side-effects of systemic illness. |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  |